| |
|
|
| |
LEXOTAN® |
| |
Product Information (Abridged) |
| |
|
|
| |
|
|
| |
|
 |
|
|
|
Properties |
|
|
|
LEXOTAN® (bromazepam) is a psychotropic drug.
In |
|
low dosage, it selectively reduces tension and anxiety. |
|
|
|
Indications |
|
|
|
LEXOTAN® is indicated for the treatment of
all |
|
conditions arising from emotional over-reaction to |
|
stressful situations and conflicts: |
|
|
Tension and anxiety states |
Anxious, agitated depressive reactions |
|
Nervousness, stress and overstrain, minor agitation,
autonomic dysfunction. |
Phobias, obsessive and compulsive neuroses. |
As adjuvant in functional disturbances in the
cardiovascular, respiratory gastrointenstinal and
genitourinary systems. |
Psychosomatic disorders: gastric and duodenal ulcer,
ulcerative colitis, asthma etc. |
Anxious – depressive reactions in chronic somatic
illness. |
|
|
|
Dosage |
|
|
|
Average dose for all patient therapy:
1.5 – 3mg three times daily, severe cases, especially in
hospital: 6 – 12mg two or three times daily.
These are average recommendations, and dosage should be
individually determined. Treatment of out patients in
general begins with the lowest dose, gradually
increasing if necessary to the optimum level. After
about three to six weeks, according to progress in
therapy, dosage can usually be gradually reduced and
then stopped. |
|
|
|
Side
effects |
|
|
|
LEXOTAN® is well
tolerated. Side effects such as fatigue, drowsiness and
rarely muscle weakness can occur with high doses. |
|
|
|
Contraindication |
|
|
|
Myaesthenia gravis |
|
|
|
Precautions |
|
|
|
Elderly and debilitated patients
require cautious dosage because of individual variations
in sensitivity to psychotropic medication. If LEXOTAN®
is combined with other centrally acting drugs such as
neuroleptics, tranquillizers, antidepressants,
hypnotics, analgesics and anaesthetics, it should be
borne in mind that pronounced sedation may result. This
intensification can sometimes be exploited
therapeutically. With LEXOTAN® as with other
psychoactice substances, patients should avoid taking
alcohol while under the influence of the treatment,
since the individual response cannot be forseen. Like
all medicament of this type, LEXOTAN® may
modify the patient’s reactions (driving ability,
behaviour in traffic etc) to a varying extent depending
on dosage, administration and individual susceptibility. |
|
|
|
Packs |
|
|
|
Tablets (scored) 1.5mg - 30, 500 |
|
Tablets (Scored) 3.0mg - 30, 500 |
|
|
|
|